Content validity of the comprehensive international classification of functioning, disability and health (ICF) core set for low back pain from the perspective of physicians: a … C Glocker, I Kirchberger, A Gläßel, A Fincziczki, G Stucki, A Cieza Chronic Illness 9 (1), 57-72, 2013 | 31 | 2013 |
Galactorrhea during antipsychotic treatment: results from AMSP, a drug surveillance program, between 1993 and 2015 C Glocker, R Grohmann, R Engel, J Seifert, S Bleich, S Stübner, S Toto, ... European archives of psychiatry and clinical neuroscience, 1-11, 2021 | 9 | 2021 |
A case series of serious and unexpected adverse drug reactions under treatment with cariprazine J Heck, J Seifert, DO Stichtenoth, C Schroeder, A Groh, GR Szycik, ... Clinical Case Reports 9 (5), e04084, 2021 | 6 | 2021 |
Fatal agranulocytosis associated with quetiapine in monotherapy: a case report C Glocker, R Grohmann, H Schulz Journal of Clinical Psychopharmacology 37 (5), 625-627, 2017 | 6 | 2017 |
Lifestyle behaviors, metabolic disturbances, and weight gain in psychiatric inpatients treated with weight gain-associated medication MS Simon, B Barton, A Zagler, K Engl, L Rihs, C Glocker, R Musil European Archives of Psychiatry and Clinical Neuroscience 273 (4), 839-851, 2023 | 5 | 2023 |
A comprehensive approach to predicting weight gain and therapy response in psychopharmacologically treated major depressed patients: A cohort study protocol MS Simon, BB Barton, C Glocker, R Musil Plos one 17 (7), e0271793, 2022 | 3 | 2022 |
Antipsychotic drug-induced neutropenia: results from the AMSP drug surveillance program between 1993 and 2016 C Glocker, R Grohmann, G Burkhardt, J Seifert, S Bleich, T Held, S Toto, ... Journal of Neural Transmission 130 (2), 153-163, 2023 | 2 | 2023 |
Was tun, wenn das Körpergewicht unter Psychopharmaka ansteigt? B Barton, M Simon, C Glocker, R Musil InFo Neurologie+ Psychiatrie 22, 30-39, 2020 | 2 | 2020 |
Validation of the Comprehensive ICF Core Set for Low Back Pain C Glocker lmu, 2010 | 2 | 2010 |
Atypical dyskinesias under treatment with antipsychotic drugs: Report from the AMSP multicenter drug safety project J Baumgärtner, R Grohmann, S Bleich, C Glocker, J Seifert, S Toto, ... The World Journal of Biological Psychiatry 23 (2), 151-164, 2022 | 1 | 2022 |
Who is at risk for weight gain after weight‐gain associated treatment with antipsychotics, antidepressants, and mood stabilizers: A machine learning approach J Eder, C Glocker, B Barton, E Sarisik, D Popovic, J Lämmermann, A Knaf, ... Acta Psychiatrica Scandinavica, 2024 | | 2024 |
Edema related to treatment with psychotropic drugs J Engel, B Haack, O Zolk, T Greiner, M Heinze, S Toto, J Seifert, S Bleich, ... Journal of Neural Transmission, 1-14, 2024 | | 2024 |
Deconstructing depression by machine learning: the POKAL-PSY study J Eder, L Pfeiffer, SP Wichert, B Keeser, MS Simon, D Popovic, C Glocker, ... European Archives of Psychiatry and Clinical Neuroscience, 1-13, 2023 | | 2023 |
Weight gain and treatment with psychotropic drugs: Background and management J Eder, MS Simon, C Glocker, R Musil Der Nervenarzt, 2023 | | 2023 |
Gewichtszunahme unter Therapie mit Psychopharmaka J Eder, MS Simon, C Glocker, R Musil Der Nervenarzt 94 (9), 859-869, 2023 | | 2023 |
Erratum zu: Was tun, wenn das Körpergewicht unter Psychopharmaka ansteigt? B Barton, M Simon, C Glocker, R Musil InFo Neurologie+ Psychiatrie 23, 58-58, 2021 | | 2021 |
Galactorrhea duringantipsychotic treatment: results fromAMSP, adrug surveillance program, between1993 and2015 C Glocker, R Grohmann, R Engel, J Seifert, S Bleich, S Stübner, S Toto, ... | | 2021 |
Validation of the comprehensive ICF core set for low back pain: the perspective of physicians C Glocker München, Univ., Diss., 2010, 2010 | | 2010 |